维普中文期刊产品整合服务
266篇 您的检索式:作者名="Cheung KM"
    题名 作者 年代 出处 被引量
1Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy显示文摘Hepatitis due to hepatitis B virus(HBV) reactivation can be severe and potentially fatal, but is preventable. HBV reactivation is most commonly reported in patients receiving cancer chemotherapy, especially rituximabcontaining therapy for hematological malignancies and those receiving stem cell transplantation. All patients with hematological malignancies receiving anticancer therapy should be screened for active or resolved HBV infection by blood tests for hepatitis B surface antigen(HBs Ag) and antibody to hepatitis B core antigen(antiHBc). Patients found to be positive for HBs Ag should be given prophylactic antiviral therapy to prevent HBV reactivation. For patients with resolved HBV infection, no standard strategy has yet been established to prevent HBV reactivation. There are usually two options. One is pre-emptive therapy guided by serial HBV DNA monitoring, whereby antiviral therapy is given as soon as HBV DNA becomes detectable. However, there is little evidence regarding the optimal interval and period of monitoring. An alternative approach is prophylactic antiviral therapy, especially for patients receiving highrisk therapy such as rituximab, newer generation of anti-CD20 monoclonal antibody, obinutuzumab or hematopoietic stem cell transplantation. This strategy may effectively prevent HBV reactivation and avoid the inconvenience of repeated HBV DNA monitoring. Entecavir or tenofovir are preferred over lamivudine as prophylactic therapy. Although there is no well-defined guideline on the optimal duration of prophylactic therapy, there is growing evidence to recommend continuing prophylactic antiviral therapy for at least 12 mo after cessation of chemotherapy, and even longer for those who receive rituximab or who had high serum HBV DNA levels before the start of immunosuppressive therapy. Many novel agents have recently become available for the treatment of hematological malignancies, and these agents may be associated with HBV reactivation. Although there is currently limited evidence to guide the optimal preventive measures, we recommend antiviral prophylaxis in HBs Ag-positive patients receiving novel treatments, especially the Bruton tyrosine kinase inhibitors and the phosphatidylinositol 3-kinase inhibitors, which are B-cell receptor signaling modulators and reduce proliferation of malignant B-cells. Further studies are needed to clarify the risk of HBV reactivation with these agents and the best prophylactic strategy in the era of targeted therapy for hematological malignancies.Man Fai Law Rita Ho Carmen KM Cheung Lydia HP Tam Karen Ma Kent CY So Bonaventure Ip Jacqueline So Jennifer Lai Joyce Ng Tommy HC Tam 2016World Journal of Gastroenterology2016,22,28:10
2Regeneration of intervertebral disc by mesenchymal stem ceils : potentials, limitations, and future direction 显示文摘Leung VY Chan D Cheung KM 2006Eur Spine J2006,3,:1
3Assessment of scoliosis cor-rection in relation to flexibility using the fulcrum bending correc-tion index显示文摘Luk KD Cheung KM Lu DS 1998Spine(Phila Pa 1976)1998,23,21:1
4Assessment of scoliosis correction in relation to flexibility using the fulcrum bending correction index 显示文摘Luk KD Cheung KM Lu DS 1998Spine ( Phila Pa 1976 )1998,23,21:1
5Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors显示文摘Chen Y Luk KD Cheung KM 0,,16:1
6hypokalemic metabolic acidosis attributed to cough mixture abuse显示文摘Wong KM Cha KWL Cheung CY 2001Am J Kidney Dis2001,38,2:1
7Phenotypic and population differences in the association between CILP and lumbar disc disease显示文摘Virtanen IM Song YQ Cheung KM 2007J Med Genet2007,44,4:1
8Delayed stimulatory effect of low - intensity shock waves on human periostealcells 显示文摘Tam KF Cheung WH Lee KM 2005Clin Orthop Relat Res2005,438,:1
9Atypical squamous cells of undetermined significance on cervical smears:follow-up study of an Asian screening population显示文摘Cheung AN Szeto EF Ng KM 2004Cancer2004,102,2:1
10Adeno-associated virus-mediated bone morphogenetic protein-4 gene therapy for in vivo bone formation显示文摘Lok KD Chen Y Cheung KM 0,,:1
11Lumbar disc de- generation is linked to a carbohydrate sulfotransferase 3 vari- ant显示文摘Song YQ Karasugi T Cheung KM 2013J Clin Invest2013,123,11:1
12Transvenous embolisation of dural carotid-cavernous fistulas by multiple venous routes:a series of 27 cases显示文摘 Chan CM Cheung YL 2003Acta Neurochir (Wien)2003,145,:1
13Reliability and con-current validity of the adapted Chinese version of ScoliosisResearch Society-22(SRS-22)questionnaire显示文摘Cheung KM Senkoylu A Alanay A 2007Spine(PhilaPa 1976)2007,32,10:1
14Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis:correlation with ofloxacin susceptibility显示文摘Kam KM Yip CW Cheung TL 0,,01:1
15Ten-year follow-up study of lower thoracic hemivertebrae treated by convex fusion and concave distraction显示文摘Cheung KM Zhang JG Lu DS 2002Spine2002,27,7:1
16Outcome assessment of braeing in adolescent idiopathic seoliosis hy the use of the SRS-22 questionnaire 显示文摘Cheung KM Cheng EY Chan SC 2007Int Orthop2007,31,4:1
17Deeellularization of chondro- cyte - encapsulated collagen microspheres : a three - dimensional model to study the effects of acellular matrix on stem cell fate 显示文摘Cheng HW Tsui YK Cheung KM 2009Tissue Eng Part C Methods2009,4,:1
18Effect of melatonin suppression on scoliosis development in chickens by either constant light or surgical pinealectomy 显示文摘Cheung KM Lu DS Poon AM 2003Spine2003,17,:1
19Transvenous embolization of dural carotid cavernous fistulas by multiple venous routes:A series of 27 cases显示文摘Cheng KM Chan CM Cheung YL 2003Acta Neurochir2003,145,:1
20Prediction of correction of scoliosis with use ofthe fulcrum bending radiograph显示文摘Cheung KM Luk KD 1997J Bone Joint Surg(Am)1997,79,8:1
返回顶部 每页显示:
共14页 首页 上一页 第1页 下一页 末页 /14 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费